Long-term therapy of the Parkinson syndrome
Ludin, H.P.
Schweizerische Medizinische Wochenschrift 114(33): 1131-1136
1984
ISSN/ISBN: 0036-7672 PMID: 6484543 Document Number: 238629
The various drugs available for the treatment of parkinsonism (anticholinergics, L-dopa plus decarboxylase inhibitor, dopamin agonists, amantadine, deprenyl) and stereotaxic surgery are briefly presented. The most important problems of longterm treatment, i.e. dyskinesias, mental disturbances, orthostatic hypotension, decrease of drug effect, on-off-phenomena, are discussed. Finally, some practical suggestions for therapy are given.
Document emailed within 1 workday
Related Documents
Fischer, P.A. 1987: Long-term course in Parkinson's syndrome and cerebral polypathy (Parkinson plus) Advances in Neurology 45: 235-238Christiani, K.; Möller, W.D. 1973: Drug therapy of Parkinson's syndrome. Clinical long-term study using L-dopa and the drug conbination L-dopa-decarboxylase inhibitor Münchener Medizinische Wochenschrift 115(16): 711-713
1997: Parkinson disease--planning of long-term therapy Der Nervenarzt 68(12 Suppl Morbus Par): 1-8
Antóny, M.; Tóth, G.; Széplaki, Z. 1982: Clinicopharmacological study of long-term Jumex + Dopaflex combination treatment in Parkinson's syndrome Therapia Hungarica 30(4): 168-171
Botez, M.I.; Barbeau, A. 1975: Neuropsychological findings in Parkinson's disease: a comparison between various tests during long-term levodopa therapy International Journal of Neurology 10(1-4): 222-232
Fuchs, G. 1997: Parkinson disease--problems in long-term treatment. Dopamine agonists optimize L-dopa therapy Fortschritte der Medizin 115(5): 43-45
Mikhaĭlov, A.A.; Dvoretskiĭ, L.I.; Kuznetsova, O.P.; Iaroslavtseva, G.N.; Vorob'ev, P.A.; Sura, O.V.; Miagkov, A.V.; Medvedeva, T.P.; Bogachev, V.V.; Sukhomlinova, L.V. 1991: Intensive therapy of DIC-syndrome in patients with acute renal insufficiency caused by long-term crush syndrome Klinicheskaia Meditsina 69(5): 80-84
Menninger, H.; Burkhardt, H. 1983: Long-term drug therapy in inflammatory rheumatic diseases using chronic polyarthritis as an example. 2. Basic principles of long-term drug therapy: choice of optimal therapeutic agents Fortschritte der Medizin 101(14): 639-645
Djulepa, J. 1980: Prostatic syndrome. Long term therapy with Prostamed ZFA. Zeitschrift für Allgemeinmedizin 56(11): 813-816
Volpi, A.; Meroni, M.; Battini, G.; Torri-Tarelli, L.; Conte, F.; Ferrario, G.; Giordano, F.; Tommasi, A.; Fabbri, C.; Sessa, A. 1988: Long-term captopril therapy of 3 sisters with Bartter's syndrome Minerva Urologica e Nefrologica 40(1): 61-66
Waldecker, B.; Frees, U.; Brachmann, J.; Thorspecken, R.; Kübler, W. 1989: Long-term results of pacemaker therapy in hypersensitive carotid sinus syndrome Zeitschrift für Kardiologie 78(7): 453-458
Sancewicz-Pach, K.; Słowiaczek, E.; Kwinta-Rybicka, J.; Wilkosz, K.; Drozdz, D.; Nowak, J. 1996: Long-term Cyclosporine A (Sandimmun) therapy for steroid resistant nephrotic syndrome in children Przeglad Lekarski 53(4): 365-368
Pietrzyk, A.; Zgierska, A.; Pływaczewski, R.; Zieliński, J. 1997: The effect of long-term therapy of obstructive sleep apnea syndrome with CPAP for symptoms of daytime sleepiness Wiadomosci Lekarskie 50(10-12): 295-299
Clough, C.G.; Bergmann, K.J.; Yahr, M.D. 1984: Cholinergic and dopaminergic mechanisms in Parkinson's disease after long-term L-DOPA administration Advances in Neurology 40: 131-140
De Vita, S.; Quartuccio, L.; Salvin, S.; Picco, L.; Scott, C.A.; Rupolo, M.; Fabris, M. 2014: Sequential therapy with belimumab followed by rituximab in Sjögren's syndrome associated with B-cell lymphoproliferation and overexpression of BAFF: evidence for long-term efficacy Clinical and Experimental Rheumatology 32(4): 490-494
Molina, J.A.; Jiménez-Jiménez, F.J.; Ortí-Pareja, M. 1999: Motor and mental complications in the long-term treatment of complicated Parkinson's disease with levodopa Revista de Neurologia 28(10): 982-990
Selby, G. 1984: The Graeme Robertson memorial lecture, 1983. The long-term prognosis of Parkinson's disease Clinical and Experimental Neurology 20: 1-25
Birkmayer, W.; Riederer, P.; Ambrozi, L.; Youdim, M.B. 1977: Implications of combined treatment with 'Madopar' and L-deprenil in Parkinson's disease. A long-term study Lancet 1(8009): 439-443
1989: 3rd Symposium on a Long Term Clinical Care of Parkinson's Disease. Tokyo, April 23, 1988. Proceedings European Neurology 29 Suppl. 1: 1-38
Solti, F.; Szatmáry, L.; Rényi-Vámos, F.; Szabó, Z. 1987: Pacemaker therapy for the treatment of the long QT syndrome associated with long-lasting bradycardia and ventricular tachycardia. Electrophysiological characteristic and therapy Cor et Vasa 29(6): 428-435